Gender differences in smoking quit rates are frequently reported and are the subject of much speculation. This study examined the generalizability of gender differences in abstinence across study sites, treatments, and time of relapse, as well as potential mediators and moderators of gender effects. Participants were smokers who participated in 3 randomized clinical trials of the nicotine patch ( N = 632). Men had higher cessation rates than women at all follow-ups. The impact of gender on abstinence was unaffected by controlling for study site, treatment, or time of relapse. There was little evidence for mediation or moderation of this relation by any of a host of predictor variables. The magnitude and consistency of the gender differential, coupled with an inability to account for it, highlights a compelling need for additional research specifically aimed at elucidating the relation between gender and abstinence. This study was supported by a research grant from Elan Pharmaceutical Research Corporation, Gainesville, Georgia, and Athlone, Ireland. Correspondence may be addressed to David W. Wetter, Center for Health Studies, Group Health Cooperative, 1730 Minor Avenue, Suite 1600, Seattle, Washington, 98101-1448. Electronic mail may be sent to wetter.d@ghc.org Received: May 11, 1998 Revised: September 21, 1998 Accepted: October 27, 1998 Research on gender differences in smoking quit rates has suggested that men are more likely than women to successfully quit smoking. Population-based data indicate that the quit ratio (former smokers to ever smokers) is consistently higher for men (52%) than for women (47%; Centers for Disease Control and Prevention, 1994 ), and smoking prevalence curves within comparable birth cohorts show less quitting for Journal of Consulting and Clinical Psychology
women than for men ( Escobedo & Peddicord, 1996 ) . Recent data from two large community intervention trials also suggest that women have lower rates of quitting than men Community Intervention Trial for Smoking Cessation Research Group, 1995 ) . Finally, our own research on smokers seeking treatment reveals that men have higher cessation rates than do women Wetter et al., 1994 ) . These results are consistent with conclusions made almost 20 years ago in the Surgeon General's report that "women have more difficulty giving up smoking than men" ( U.S. Department of Health and Human Services, 1980, p. 307 ) . However, gender by itself is not a theoretically or clinically meaningful explanatory factor. Identifying the mechanisms through which gender influences smoking relapse, or identifying subgroups of men or women at particularly high risk for relapse, requires examining the association of gender and abstinence in conjunction with other variables.
Mediator variables typically explain how or why a predictor variable influences an outcome variable ( Baron & Kenny, 1986 ) . That is, a mediator represents a mechanism through which gender influences abstinence and provides a potential target of intervention. Moderator variables influence the strength or direction of the association between the predictor and dependent variable (i.e., there is an interaction between gender and the moderator variable when predicting abstinence; Baron & Kenny, 1986 ) . Moderator variables are useful in identifying subgroups that might be particularly vulnerable to relapse.
Gender differences in abstinence have been attributed to numerous factors (e.g., depression, nicotine dependence, withdrawal, and demographics). Perhaps the most common hypotheses concern the notion that negative affect, stress, and depression are especially determinant of outcomes among women ( Borrelli, Bock, King, Pinto, & Marcus, 1996 ) . Depression is associated with a decreased likelihood of quitting smoking ( Glassman et al., 1990 ) and is more prevalent among women than among men ( Angst, 1992 ) . Therefore, women may be less successful than men at quitting smoking because of the mediating effect of depression on cessation. Similar arguments have been advanced for negative affect and stress. Alternatively, depression, negative affect, and stress may moderate the relation of gender with abstinence, presumably by exerting a more pronounced effect among women than among men ( Borrelli et al., 1996 ) . However, there is little research that explores how affective variables influence the relation of gender and outcome; and to the extent that such data exist, they are inconsistent, sometimes appearing to be a more important risk factor for men ( Glassman et al., 1990 ) and other times for women ( Covey, Hughes, Glassman, Blazer, & George, 1994 ) . Therefore, at present it is unclear whether the investigation of affective and stress variables can elucidate gender differences in cessation outcomes.
Gender differences in abstinence have also been ascribed to nicotine-related variables ( Grunberg, Winders, & Wewers, 1991 ) . For example, nicotine withdrawal and dependence measures predict abstinence, and there is some evidence that withdrawal severity may be greater among women ( Hatsukami, Skoog, Allen, & Bliss, 1995 ) or may interact with gender such that it is more strongly related to relapse among women than among men ( Gunn, 1986 ) . With respect to nicotine dependence, women often display lower levels of dependence on both self-report and biochemical measures than do men (see Perkins, 1996 ) . Thus, it is unlikely that nicotine dependence mediates the effects of gender on abstinence. However, in at least one study, dependence functioned as a moderator variable such that its effects on abstinence were stronger among women than among men ( Jackson, Stapleton, Russell, & Merriman, 1986 ) . Perkins (1996) has posited specific mechanisms that might underlie gender differences in treatment response. He has argued that nicotine replacement therapies are less effective for women than for men because the reinforcement that women derive from smoking is thought to be less dependent on nicotine per se. Consequently, nicotine replacement therapies should moderate gender effects on abstinence.
Finally, some researchers have suggested that demographic variables might explain gender differences in http://spider.apa.org/ftdocs/ccp/1999/august/ccp674555.html 8/30/2000 abstinence. For example, women might have poorer outcomes because they have lower levels of education and less education is related to relapse . Other variables that have been posited to account for gender differences in abstinence include age ( Jarvis, 1994 ) , smoking outcome expectancies , coping strategies ( Blake et al., 1989 ) , and health symptoms .
Unfortunately, when gender differences in quit rates have been found, the identification of mediators and moderators of gender effects has been problematic for several reasons. First, many studies do not report mediation or moderation analyses after gender differences in abstinence are found (ourselves included; Wetter et al., 1994 ) . Second, if gender differences are found on both outcome and predictor variables, it is often simply assumed that gender differences in abstinence are accounted for by the differences on the predictor variables. However, without mediation analyses, it is difficult if not impossible to determine whether gender differences are mediated by any of the predictor variables. Third, many attempts to identify mediator and moderator effects are characterized by inaccuracies in terminology, conceptualization, or data analysis ( Holmbeck, 1997 ) . For example, Bjornson et al. (1995) discussed results from the Lung Health Study as if education were a moderator, but in fact, the interaction of gender with education was not significant. Finally, data on potential mediators and moderators are often inconsistent across studies.
The present research examined the relation between gender and abstinence among smokers who participated in three nicotine patch clinical trials Wetter et al., 1994 ) . More specifically, the present investigation evaluated gender effects on abstinence across study sites, treatment characteristics, and time of relapse, as well as a host of potential mediator and moderator variables that have been either empirically linked to gender differences in abstinence or represent key theoretical constructs that should be related to abstinence. Potential mediator and moderator variables examined included demographics, treatment characteristics, nicotine dependence, smoking history, negative affect, stress, depression history, smoking outcome expectancies, coping style, health symptoms, tobacco withdrawal, and postcessation negative affect and stress.
Method Participants and Procedures
Participants were smokers who participated in three randomized, double-blind, placebo-controlled clinical trials of the nicotine patch for smoking cessation ( N = 632; Fiore et al., 1994 ) . Four sites participated in the first trial ( n = 280), a single site in the second trial ( n = 112), and three sites in the third trial ( n = 240). Participants at all sites were selected according to identical inclusion and exclusion criteria. Inclusion criteria were as follows: 21 to 65 years of age, a history of smoking 15 or more cigarettes/day during the past year, an expired air carbon monoxide (CO) level of 10 parts per million (ppm) or greater, and motivation to quit smoking. Exclusion criteria were as follows: presence of cardiovascular disease, pregnancy or lactation, regular use of psychotropic drugs, current symptomatic psychiatric disorder, current alcohol or drug abuse, chronic dermatologic disorders, and use of any experimental medication during the past 30 days.
With only minor variations, all study procedures and measures were identical across clinical trials and study sites. Half the study participants at each site received active nicotine patches and half received placebo patches. In the first trial, participants received weekly group counseling for 8 weeks. In the second and third trials, participants received weekly individual counseling for 8 weeks. Counseling emphasized coping skills training and identifying high-risk situations ( Marlatt & Gordon, 1985 ) .
Measures Baseline.
Baseline measures were collected prior to quitting smoking. Nicotine dependence and smoking history measures included the following: serum nicotine (nanograms per kilogram of body weight [ng/kg]), serum cotinine (ng/kg), expired air CO level (ppm), cigarettes per day, years smoked, and the Fagerstrom Tolerance Questionnaire (FTQ; Fagerstrom, 1978 ) .
We assessed negative affect and perceived stress using the Positive and Negative Affect Scale (PANAS; Watson, Clark, & Tellegen, 1988 ) and the Perceived Stress Scale (PSS; Cohen, Kamarck, & Mermelstein, 1983 ) . For both measures, participants were asked to rate items for the previous week. Depression history was assessed by a single dichotomous item, "Have you ever had a period when you were feeling depressed or down most of the day nearly every day?" History of treatment for depression was a dichotomous measure assessed by a single item, "Have you ever been treated for depression?"
The Smoking Consequences Questionnaire (SCQ) was used to measure smoking outcome expectancies ( Brandon & Baker, 1991 ) . The SCQ consists of four scales: negative reinforcement, positive reinforcement, appetite/weight control, and negative consequences. Negative reinforcement, positive reinforcement, and appetite/weight control expectancies predict withdrawal severity; negative reinforcement, appetite/weight control, and negative consequences expectancies predict relapse .
Three coping styles were measured: cognitive self-control, ineffective escapism, and solace seeking ( Rohde, Lewinsohn, Tilson, & Seeley, 1990 ). This measure reflects participants' tendencies to engage in specific coping behaviors and is not smoking specific. Ineffective escapism and solace seeking predict affective disturbance ( Rohde et al., 1990 ) , and negative affect has been hypothesized to influence gender effects on smoking cessation ( Borrelli et al., 1996 ) .
All patients underwent a physical exam during evaluation for inclusion and exclusion criteria. Negative health symptoms were coded as either present or absent for three variables: respiratory symptoms; cardiovascular symptoms; and ear, nose, and throat symptoms.
Postcessation.
We assessed eight tobacco withdrawal symptoms (anger, anxiety, awakenings, difficulty concentrating, depression, hunger, impatience, and urge; Hughes & Hatsukami, 1986 ) by using single items rated on a scale ranging from 0 ( not present ) to 4 ( severe ) on a daily diary. Withdrawal ratings were collapsed across the first 7 postcessation days and a composite withdrawal index was formed from the eight individual symptoms. We measured negative affect and perceived stress by using the PANAS and the PSS, which were administered 1 week postcessation.
Abstinence.
We measured point-prevalence abstinence weekly throughouttreatment and at 6 months after quitting. Abstinence was defined as both a self-report of no smoking during the previous 7 days and a CO level of less than 10 ppm. Participants with missing data were assumed to have smoked and were classified as smokers.
Data Analyses Mediation analyses.
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To demonstrate that a variable mediates the effect of gender on abstinence, the following conditions must hold ( Baron & Kenny, 1986 ) : (a) gender must be associated with abstinence, (b) gender must be associated with the mediator, (c) the mediator must be associated with abstinence, and (d) the relation between gender and abstinence must be meaningfully reduced when controlling for the mediator.
We used logistic regression analyses to test for gender effects on abstinence across trials, study sites, and treatments. We determined the association of each potential mediating variable with gender by using t tests for continuous variables and chi-square tests for categorical variables. The association of each potential mediating variable with abstinence was tested using logistic regression analyses. Finally, logistic regression analyses tested whether the potential mediator reduced the relation between gender and abstinence. Gender was entered on the first step, and the potential mediating variable was entered on the second step. The association of gender with abstinence after the first step, as assessed by examining the regression and correlation ( R ) coefficients (without the potential mediator in the model), was then compared with the association after the second step (with the potential mediator in the model). If the relation between gender and abstinence was substantially reduced by including the variable, then mediation was presumed to have occurred.
Unstandardized regression coefficients and correlation coefficients are presented for variables in the logistic regression models. We chose to present the correlation coefficient, rather than an odds ratio (OR), because the correlation coefficient has the advantage of permitting easy comparisons across variables with respect to their strength of association with the outcome variable. For example, when using the correlation coefficient, the strength of associations between abstinence and variables on different scales of measurement (e.g., dichotomous vs. continuous variables) are presented using a common metric that allows for easy interpretation. This would not have been the case if we had used ORs.
Moderation analyses.
We performed moderation tests for each variable using logistic regression. Gender was entered on the first step, and the potential moderating variable was entered on the second step. The interaction of gender with the potential moderating variable was entered on the third step.
Other analytic considerations.
Because the clinical trials involved multiple sites, observations within each sight might be correlated. Therefore, we repeated a number of our analyses using generalized estimating equations (GEEs). GEEs adjust for the observed between-subjects correlations. However, we chose to present the results from the logistic regression analyses because the results of the GEEs and logistic regression analyses were virtually identical.
Results

Participant Characteristics
The sample consisted largely of long-term, heavy smokers. Women constituted 61% of the participants, mean age was 42.6 years ( SD = 10.1), mean number of years smoked was 24.2 ( SD = 9.9), and mean number of cigarettes smoked per day was 29.6 ( SD = 10.4). Participant characteristics by gender are http://spider.apa.org/ftdocs/ccp/1999/august/ccp674555.html 8/30/2000 shown in Table 1 .
Gender Differences in Abstinence
Abstinence analyses focused on three time points: Week 1, end of treatment (EOT), and 6 months. Men were significantly more likely than women to be abstinent at each time point (for Week 1, 42% vs. 32%, OR = 1.5, p = .01; for EOT, 45% vs. 29%, OR = 2.0, p = .0001; for 6 months, 25% vs. 12%, OR = 2.4, p = .00003). The effect of gender on abstinence was not accounted for by differences in early or late relapse alone (i.e., women were less successful than men at maintaining abstinence even when examining only those individuals who relapsed between any two particular time points). For instance, if only those individuals who were abstinent at Week 1 are examined (i.e., Week 1 relapsers are removed from the analyses), men are still more likely than women to be abstinent at EOT (OR = 2.1, p = .01) and at 6 months (OR = 2.4, p = .002; data not shown). Similarly, if only participants abstinent at the EOT are examined, men are more likely than women to still be abstinent at 6 months (OR = 1.7, p = .04; data not shown). Because of the stability of gender differences in abstinence across all time points, the analyses focused on the long-term (6-month) follow-up.
Logistic regression analyses indicated that gender differences in abstinence were unaffected by controlling for clinical trial and study site. As shown in Figures 1 A and 1B, men were more likely than women to be abstinent across all three clinical trials and across seven of the eight study sites, although not all of the individual comparisons by trial and site were significant. In addition, the gender effect remained significant after controlling for treatment characteristics (e.g., nicotine patch status and counseling type; see Figures 1C  and 1D ). Men were significantly more likely than women to quit smoking, regardless of whether they received an active ( p < .001) or placebo nicotine patch ( p = .03) or whether they received group ( p = .006) or individual counseling ( p = .002). Gender did not interact with clinical trial, site, patch status, or counseling type.
Gender Differences on Predictor Variables
Gender was significantly associated with numerous predictor variables (see Table 1 ). Men smoked more cigarettes per day, had smoked for a longer period of time, and had higher CO and serum nicotine levels than did women. Women reported higher levels of pre-and postcessation stress; negative reinforcement, appetite/weight control, and negative consequences expectancies; and cognitive self-control and solaceseeking coping styles.
Relations Between Predictor Variables and Abstinence
Predictor variables related to abstinence included those assessing nicotine dependence (serum nicotine and serum cotinine), depression history and depression treatment history, baseline stress, smoking outcome expectancies (negative reinforcement, positive reinforcement, and appetite/weight control), and postcessation measures (withdrawal severity, negative affect, and perceived stress; see Table 1 ). Only zero-order relations between predictor variables and abstinence are reported because these relations were largely unaffected by controlling for variables such as clinical trial, site, patch status, and counseling type.
Mediation Effects
Five variables were related to both gender and abstinence: serum nicotine, baseline perceived stress, negative reinforcement expectancies, appetite/weight control expectancies, and postcessation perceived http://spider.apa.org/ftdocs/ccp/1999/august/ccp674555.html 8/30/2000 stress (see Table 1 ). Serum nicotine was clearly not a mediator of gender effects on abstinence because the strength of the association actually increased slightly after controlling for serum nicotine (see Table 2 ). In addition, none of the other four potential mediators substantially reduced the association between gender and abstinence (see Table 2 ). The correlation between gender and abstinence was never reduced by more than .02 after controlling for any of the potential mediators, nor was the regression coefficient ever reduced by even 0.5 SE s after including each potential mediator in the model.
There were no meaningful mediator effects when testing the combination of the two perceived stress variables (precessation PSS and postcessation PSS), two expectancy variables (negative reinforcement and appetite/weight control), or all four variables. Controlling for patch status and counseling type had virtually no effect on any of the mediator analyses. Finally, as can be seen in Table 2 , even if the criteria required for mediation were relaxed such that variables related to both gender and abstinence at p < .25 were considered as potential mediators (e.g., depression history, depression treatment history, cigarettes per day, FTQ, serum cotinine, and CO), none of these predictor variables would have mediated the effects of gender on abstinence.
Moderation Effects
The interaction of gender with each predictor variable is shown in Table 2 . Only baseline perceived stress moderated the effect of gender on abstinence. For participants low on baseline perceived stress (median split), there was a strong gender effect, with men achieving 6-month abstinence rates of 30% relative to 12% for women (OR = 3.3, p < .001). For participants high on baseline perceived stress, the abstinence rate for men was not significantly different than that for women (17% vs. 12%, OR = 1.5, p = .28). In other words, there was an association between baseline perceived stress and abstinence for men but not for women. Controlling for patch status and counseling type had little effect on the moderator analyses.
Mediators and Moderators of Short-Term Abstinence
To examine the stability of our findings, we repeated our analyses using abstinence measured 1 week after the quit date. There were no mediation effects, nor were there any significant interactions. The interaction of gender with baseline perceived stress, which was significant when predicting long-term abstinence, was not significant.
Discussion
In this research, women were significantly less likely than men to quit smoking successfully and this effect was generalizable across study sites and treatment conditions. Gender effects were not confined to any particular postcessation period; women were more likely than men to relapse immediately after quitting, during treatment, or following treatment. However, the causes of these gender differences are unknown.
The failure to find mediators was not due to a lack of meaningful candidate variables. We examined a wide variety of potential mediators that have been either empirically or theoretically linked to gender effects on abstinence. Men and women differed on a host of these variables and many predicted outcomes, but none could account for the gender differences in abstinence. Five variables met all criteria for mediation, with the exception that they had little impact on the association of gender and outcome. For example, women held stronger negative reinforcement expectancies for smoking than did men and participants with strong expectancies were less likely to be abstinent than were those participants with weak expectancies (12% vs.
21% after a median split, p = .003). However, the relation between gender and abstinence was virtually unaffected by controlling for negative reinforcement expectancies (see Table 2 ). Relaxing the criteria required for mediation failed to reveal any effects.
Power for detecting interactions may be low when using logistic regression ( Hosmer, Hosmer, Le Cessie, & Lemeshow, 1997 ) , but when we used a more liberal criterion for determining significance, only 2 of 24 interactions were significant at p < .10 (see Table 2 ), about what would be expected by chance. More importantly, the nature of the interactions did not explain women's increased vulnerability to relapse. Rather, they identified vulnerability factors for men. In theory, the moderation of the gender-outcome relation by variables such as perceived stress could account for inconsistencies in the strength of that relation across different studies. For instance, if participants in a particular sample tend to experience high levels of perceived stress, this should be associated with a smaller gender differential in outcome. However, given that the Gender × Baseline Perceived Stress interaction was significant only at 6 months and was the single significant interaction out of 24 tested, it seems likely that factors yet to be identified influence the magnitude of the gender differential in smoking cessation rates. Perkins (1996) has hypothesized that women receive less benefit from nicotine replacement therapy because women, relative to men, smoke more for nonnicotine reinforcement and less for nicotine reinforcement.
Although there was a trend for the patch to have greater effects among men than among women at all followups (ORs = 2.7-3.0 for men vs. 2.0-2.3 for women), the patch was effective for both men and women, and women were consistently less successful at quitting smoking than were men, even among participants who received the placebo patch. It may be that a molar measure of outcome such as abstinence does not sensitively reflect more subtle gender differences in response to treatment. In other research using psychophysiological indices of outcome, we have found gender differences in response to nicotine replacement therapy that are consistent with Perkins's hypothesis ( Wetter et al., 1999 ) .
It is possible that we would have found mediators or moderators of gender effects if we had used alternative measures of hypothesized constructs. For example, we used single items to assess depression history and depression treatment history. Different results might have been obtained had we used a structured clinical interview for assessment. Nevertheless, the single items were significant predictors of abstinence (e.g., depression-history-positive smokers were much less likely to quit smoking successfully than those classified as depression history negative, 7% vs. 20%, p < .001). In addition, although there were adequate data on education only for participants in the third clinical trial, there was no evidence that education predicted abstinence or interacted with gender.
It is certainly the case that variables not assessed in this research may mediate or moderate the impact of gender on outcome (see Grunberg et al., 1991 ) . However, at present, it is difficult to identify the most promising directions to explore. For instance, women might face greater relapse risk than men because of phenomena associated with menstrual cycling, but there are few data indicating that menstrual cycling powerfully affects cessation success (see Pomerleau, 1996 ) . Meyers et al. (1997) have found that weight concerns are more common among women and that these concerns predict outcome. However, in their data, gender did not interact with weight concerns in predicting abstinence and mediation analyses were not reported ( Meyers et al., 1997 ) . Thus, their results are similar to our findings with respect to weight-control expectancies (except that we also included mediation analyses): Women in our study held stronger weightcontrol expectancies than did men, expectancies predicted abstinence, the gender effect on abstinence was not mediated by expectancies, and there was no interaction of gender and expectancies. Post hoc analyses of other weight-related variables (e.g., baseline weight, weight gain after quitting, percentage of body weight gained, and interactions among these variables) did not explain the gender differential in abstinence (data not http://spider.apa.org/ftdocs/ccp/1999/august/ccp674555.html 8/30/2000 shown). It may be that factors such as self-efficacy or readiness to quit are related to the gender differential in cessation success ( Velicer et al., 1995 ) , but there is little evidence to date that gender differences in abstinence are mediated or moderated by these variables. Another possibility is that differences in withdrawal profile shape might account for gender differences in outcome ( Piasecki, Kenford, Smith, Fiore, & Baker, 1997 ) . However, this still leaves the question of what aspect or correlate of gender produces these profile shape differences. Finally, it is possible that our exclusion of participants with current psychiatric disorders restricted the range of some predictor variables and that this restriction of range reduced our ability to identify mediator or moderator variables.
This study, like most smoking-cessation treatment research, can be criticized on the bases of limited generalizability to the general population of smokers and the possibility of differentially biased samples of men and women. However, the generalizability of our results, at least to those smokers seeking treatment, is strengthened by the consistency of the findings across time of relapse, study sites, and treatment characteristics. Furthermore, if abstinence rates were differentially affected by biases in our samples of men and women, those biases do not appear to be reflected in variables measured in the present study. That is, of the variables assessed in this study that could conceivably reflect biases in our samples of men and women (see Table 1 ), none can account for the gender differences in abstinence.
Gender differences in abstinence may be due to biological, psychological, or environmental factors ( Grunberg et al., 1991 ) . Future studies examining gender effects related to smoking need to include biopsychosocial variables and multidimensional assessments and might also examine subgroups of smokers. It may be that specific mediators exist for particular subgroups (e.g., Swan, Ward, Carmelli, & Jack, 1993 ) . Also, most mediator and moderator candidates explored thus far have been integrative self-report measures, and it may be that potent mediators and moderators will be discovered only after more focused psychobiological indices are used (Wetter et al., in press ). Finally, increasing the yield of future research might depend on the analysis of more formal, precise models of the gender-linked processes that could manifest themselves in different cessation outcomes. 
